Mr. Andreas Hober
Andreas Hober graduated from KTH Royal Institute of Technology in 2017 with a Master of Science in Engineering and was awarded the Honnörsstipendium (Best Graduate of the Year), within the Biotechnology programme. He is currently enrolled as a PhD student in the group of Targeted Proteomics at KTH Royal Institute of Technology, headed by Prof. Mathias Uhlén
Andreas Hober’s research is centered around development of targeted proteomics methods for more sensitive assays. His focus is on developing precise quantification for clinically relevant protein targets in human blood plasma to be used for precision medicine applications. Within this area, an assay for monitoring the levels of apolipoproteins in clinical cohorts has already been implemented and a SISCAPA-based method for SARS-CoV-2 diagnostics been developed. The current goal is to continue this path and develop assays for monitoring low abundant FDA approved protein targets by using affinity reagents.